Sickle Cell Disease Comprehensive Care Act

The Bill 118 hr 1672, also known as the Sickle Cell Disease Comprehensive Care Act, aims to improve the care and treatment of individuals with sickle cell disease in the United States. The bill recognizes sickle cell disease as a significant public health issue and seeks to address the disparities in access to care and treatment that individuals with sickle cell disease often face.

The key provisions of the bill include:

1. Establishing a national surveillance program to track the prevalence of sickle cell disease and monitor the quality of care provided to individuals with the disease. 2. Improving access to comprehensive care for individuals with sickle cell disease, including preventive services, treatment, and management of complications. 3. Increasing funding for research on sickle cell disease, with a focus on developing new treatments and improving outcomes for individuals with the disease. 4. Providing education and training for healthcare providers to ensure they have the knowledge and skills to effectively care for individuals with sickle cell disease. 5. Supporting community-based organizations that provide services and support to individuals with sickle cell disease and their families. Overall, the Sickle Cell Disease Comprehensive Care Act aims to address the challenges faced by individuals with sickle cell disease and improve their quality of life through better access to care, treatment, and support services. The bill has bipartisan support and is seen as a crucial step towards improving the lives of individuals with sickle cell disease in the United States.